Alimentary pharmacology & therapeuticsHumansHepatitis B VaccinesFemaleMaleAdult
Clinical Trial: Immunogenicity of Double-Dose Versus Standard-Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel Disease.
Anupam Kumar Singh, Roop Kishor Soni, Vaneet Jearth, Ashutosh Ishan Yadav, Chhagan Lal Birda, Abhirup Chatterjee, Jimil Shah, Ritin Mohindra, Amol N Patil, Vikas Suri, Vishal Sharma, Arun Kumar Sharma, Usha Dutta
Published: 202610.1111/apt.70470
Abstract
BACKGROUND: Immunogenic response to hepatitis B virus (HBV) vaccine in patients with inflammatory bowel disease (IBD) is variable and often suboptimal. AIM: To compare the immunogenicity of standard-dose (20 μg) vs. double-dose (40 μg) HBV vaccinatio…
Preview only. Read the full abstract at the source